3[1]Hansh C, Dunn WJ. Linear relationship between lipophilic character and biological activity of drugs [J]. J Pharm Sci, 1972,61(1):1-18.
4[2]Chikhale EG, Ng KY, Burton PS, et al. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides [J]. Pharm Res, 1994,11(3):412-449.
5[3]Ong S, Liu H, Qiu X, et al. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces [J]. Anal Chem, 1995,67(4):755-762.
6[4]Yang CY, Cai SJ, Liu HL, et al. Immobilized artificial membranes-screens for drug membrane interactions [J]. Adv Drug Deliv Rev, 1996,23(2):229-256.
7[5]Sun J, Deguchi Y, Chen JM, et al. Evaluating interactions of amphoteric molecules with phospholipid membrane using immobilized artificial membrane chromatography [J]. Pharmazie (in press).
8[6]Sun J, Deguchi Y, Chen JM, et al. Interactions between quinolone antibiotics and phospholipid membrane for prediction of alveolar macrophage uptake [J]. Acta Pharmacol Sin, 2002,23(5):430-438.
9[7]Ong S, Liu H, Pidgeon C. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability[J]. J Chromatogr, 1996,728(1-2):113-128.
10[8]Pidgeon C, Ong S, Choi H, et al. Preparation of mixed ligand immobilized artificial membranes for predicting drug binding to membranes [J]. Anal Chem, 1994,66(17):2701-2709.
